CMS Conditions of Participation for Outpatient Infusion Centers
Medicare now covers remote supervision of infusion centers via video.
Emilio Abara
RCM Letter — Page 2
Infusion RCM
Why Infusion Therapy Billing Demands a Purpose-Built RCM Platform
Purpose-built platforms prevent denials baked into infusion billing's unique coding mechanics.
Prior Authorization Outsourcing for Infusion Practices
Infusion practices need specialized PA workflows, not generalist billing staff scaled up.
Callum Holloway
More From RCM Letter
Modifier 25 Use in Infusion Encounters With Same-Day E&M
Modifier 25 unlocks separate payment when E&M work truly stands apart from the infusion.
Suri Eldridge
CARC and RARC Code Interpretation for Infusion Remittances
CARC and RARC codes reveal why infusion claims deny and how to fix them without guessing.
Vera Calloway
Infusion RCM Vendor Transition Playbook for Mid-Size Practices
How to navigate vendor switches without disrupting high-stakes infusion billing cycles.
Suri Eldridge
Business Plan Financial Model for a New Infusion Center
How to build a financial model that accounts for drug costs, prior auth delays, and denial risk.
Vera Calloway
Best Infusion Denial Management Approaches for High-Volume Payer Contracts
Practices that track denials by payer catch patterns most miss.
Suri Eldridge
Infusion Denial Recovery by Payer Behavior vs Root Cause Why the Grouping Method Changes Your Win Rate
Grouping denials by root cause instead of payer language doubles your appeal win rate.
Callum Holloway
N130 Remark Code and Infusion Remittance Disputes
N130 remark codes need the right CARC to tell you whether to appeal, correct, or write off.
Suri Eldridge
Coinsurance Liability for High-Cost Biologic Infusions
Patients with coinsurance on biologics face five-figure bills that derail collections and treatment.
Vera Calloway
Infusion Pharmacy RCM Mergers and Acquisitions Considerations
High denial rates and systemic RCM failures can erase the earnings buyers are actually paying for.
Vera Calloway